semaglutide vs dapagliflozin SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application Semaglutide ameliorates diabetes-associated cognitive dysfunction

GLP-1 receptor agonists like semaglutide and tirzepatide work through an entirely different mechanismthey bind to glucagon-like peptide-1 receptors in the pancreas and brain, slowing gastric emptying, enhancing satiety, and improving blood sugar control

These are the same dose-dependent GI effects seen across many oral supplements taken at gram scale, and they reverse when the dose is reduced

Its exact mechanism of action remains partially elucidated, but evidence suggests it interacts with GABAergic, serotonergic, and hypothalamic pathways to influence central nervous system activity

Do you frequently feel the need to urinate